Vanda Pharmaceuticals Inc.
VNDA
$3.92
-$0.06-1.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.49M | -4.91M | -5.32M | -4.52M | -4.15M |
| Total Depreciation and Amortization | 1.98M | 1.97M | 1.97M | 1.97M | 2.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.72M | 404.00K | -1.58M | 235.00K | 2.51M |
| Change in Net Operating Assets | -1.91M | 718.00K | -9.64M | -4.61M | 6.98M |
| Cash from Operations | -33.15M | -1.82M | -14.58M | -6.93M | 7.57M |
| Capital Expenditure | -436.00K | -214.00K | -161.00K | -1.63M | -2.71M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 44.34M | 4.21M | 12.22M | -13.63M | -15.51M |
| Cash from Investing | 43.90M | 3.99M | 12.06M | -15.26M | -18.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -409.00K | -155.00K | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -915.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.32M | -155.00K | -- | -- | -- |
| Foreign Exchange rate Adjustments | 49.00K | -202.00K | 68.00K | -15.00K | -14.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.48M | 1.82M | -2.46M | -22.21M | -10.66M |